In business, some leaders build for headlines. Others build for the moment when the market finally catches up. Neil Batlivala appears to belong to the second group.
The Pair Team CEO has spent years building a healthcare company around a population many startups ignored and a care model many investors once viewed as too operationally complex to scale. Now, with Pair Team selected as one of 150 participants in CMS’s new ACCESS program, Batlivala’s long game is coming into focus. What once looked like a difficult and unglamorous corner of healthcare increasingly looks like a leadership play built for where medicine, AI, and public reimbursement are all heading next.
ACCESS, short for Advancing Chronic Care with Effective, Scalable Solutions, is a 10-year Medicare model focused on chronic conditions including diabetes, hypertension, chronic kidney disease, obesity, depression, and anxiety. The program is scheduled to begin on July 5 of this year. Pair Team’s inclusion matters because the model is designed around outcomes, not just activity. That creates a very different kind of opportunity for companies that use AI to support ongoing care outside the traditional office visit.
That is where Batlivala’s strategic discipline stands out.
Many healthcare founders have tried to wedge AI into old reimbursement systems. Batlivala appears to have built the company the other way around. Pair Team’s model combines clinical teams, AI support, and community partnerships to address not only medical needs, but also food access, housing, transportation, and behavioral health. On its website, the company describes its approach as whole-person care for Medicaid and Medicare patients, with Flora, its AI care advocate, helping coordinate care around the clock. That is not a side feature. It is central to how the business operates.
From a CEO perspective, this is what makes Batlivala worth watching. He did not simply launch an AI tool and hope the system would adapt. He built an organization around a difficult problem, then aligned technology, staffing, and care delivery around solving it at scale. Pair Team says it supports patients through clinicians, AI, and more than 100 local partners, while helping connect members to care that spans medical, behavioral, and social support.
That positioning now looks unusually well timed.
American business leaders often talk about product-market fit. In highly regulated industries, there is another test that matters just as much: policy-market fit. Batlivala seems to have recognized that the future of healthcare AI would not be decided only by model performance or interface design. It would be decided by whether payment systems reward continuous, technology-enabled care. ACCESS signals that Medicare is beginning to move in that direction, and Pair Team is already standing there with a model designed to meet the moment.
There is also a leadership lesson in the company’s chosen customer base. Pair Team has focused on patients whose health outcomes are deeply shaped by instability in everyday life. That is a far less fashionable path than building for affluent consumers or enterprise software buyers, but it may prove more durable. CEOs who win over the long run often build where the problem is painful, expensive, and difficult to ignore. Chronic care for vulnerable populations checks every one of those boxes.
On Pair Team’s site, the company highlights services that range from housing support and food access to clinical coordination and mental health support. Flora, the company’s AI care advocate, is positioned as a way to help patients navigate care needs while escalating to human clinicians when needed. In business terms, that suggests Batlivala is not treating AI as a replacement story. He is treating it as a force multiplier for a human-led system. That is a more credible strategy in healthcare, where trust, compliance, and patient complexity all matter.
For American CEO readers, the bigger point is this: Batlivala’s rise is not just a healthcare story. It is a case study in leadership under constraints.
He is operating in one of the most regulated sectors in the economy. He is serving populations that require high-touch coordination. He is building with AI in an environment where execution mistakes carry ethical and operational consequences. And yet instead of waiting for the system to get easier, he has built within the complexity. That is often where category-defining leadership shows up.
This moment does not remove the risks. AI in healthcare still raises serious questions around privacy, reliability, reimbursement, and oversight. Public programs can shift. Economics can tighten. Execution can falter. But CEOs are ultimately judged not only by how they manage certainty, but by how clearly they place bets in uncertain environments.
Batlivala’s bet is now becoming visible. He built Pair Team around the idea that the future of care would be continuous, coordinated, and increasingly AI-enabled. With Medicare now creating a framework that appears to support exactly that kind of model, his company is no longer early in the wrong market. It may simply have been early in the right one.
For a CEO, that is one of the hardest things to get right. And when it happens, the payoff is not just growth. It is relevance at exactly the moment the industry starts looking for answers.
